Possible Administrative Guidance against 医薬・生活衛生局
For developers: integration details
You do not need this for normal browsing. Use it when integrating this enforcement record into an internal tool or AI workflow.
/api/v1/enforcements?company=%E5%8C%BB%E8%96%AC%E3%83%BB%E7%94%9F%E6%B4%BB%E8%A1%9B%E7%94%9F%E5%B1%80&limit=10Action summary
- Company
- 医薬・生活衛生局Japanese originalOriginal: 医薬・生活衛生局
- Entity match
- Possible entity match60/100Machine extractedCompany name extracted from the Japanese public disclosure
- Governing law
- 薬事規制に関する守秘取り決め薬事規制に関する守秘取り決め
- Action type
- Administrative Guidance行政指導
- Action date
- 20 June 2017
- Issuing authority
- Ministry of Health, Labour and Welfare厚生労働省
Violation
Entered into a confidentiality agreement with the United States Pharmacopeia regarding drug regulation to strengthen cooperation.
Show original Japanese text
米国薬局方協会と薬事規制に関する守秘取り決めを締結し、協力関係の強化を図った。
Compliance context
Low-mediumAdministrative guidance or supervision was publicly disclosed by the authority.
Japanese regulatory disclosure under 薬事規制に関する守秘取り決め.
Use as a monitoring signal. Confirm details before treating it as a formal sanction.
This context is an operational aid for review workflows, not a credit opinion or legal conclusion.
Evidence pack
- Extracted at
- 2026-04-25T00:11:32.447+00:00
- Evidence checked
- 2026-04-25T00:11:32.447+00:00
- Archive captured
- 2026-04-06T18:03:09.775+00:00
Show audit JSON
{
"record": {
"id": "33e00aad-adfa-4109-83c8-a924c5830809",
"url": "https://regbase.jp/en/enforcement/other-yi-yao-sheng-huo-wei-sheng-ju-20170620",
"company_name_original": "医薬・生活衛生局",
"company_name_registry": "医薬・生活衛生局",
"corporate_number": null,
"law": {
"ja": "薬事規制に関する守秘取り決め",
"en": "薬事規制に関する守秘取り決め"
},
"action_type": {
"ja": "行政指導",
"en": "Administrative Guidance"
},
"authority": {
"ja": "厚生労働省",
"en": "Ministry of Health, Labour and Welfare"
}
},
"entity_match": {
"status": "possible",
"confidence": 60,
"method": "extracted_japanese_name",
"method_label": "Company name extracted from the Japanese public disclosure",
"notes": null
},
"review": {
"status": "unreviewed",
"label": "Machine extracted"
},
"compliance_context": {
"severity": "Low-medium",
"actionMeaning": "Administrative guidance or supervision was publicly disclosed by the authority.",
"practicalNote": "Use as a monitoring signal. Confirm details before treating it as a formal sanction.",
"lawContext": "Japanese regulatory disclosure under 薬事規制に関する守秘取り決め."
},
"evidence": {
"recordUrl": "https://regbase.jp/en/enforcement/other-yi-yao-sheng-huo-wei-sheng-ju-20170620",
"officialSourceUrl": "https://www.mhlw.go.jp/stf/houdou/0000170063.html",
"archiveUrl": "https://kiroku.today/view/d142f032b8ni0l9q",
"archiveCapturedAt": "2026-04-06T18:03:09.775+00:00",
"extractedAt": "2026-04-25T00:11:32.447+00:00",
"translatedAt": "2026-05-01T07:01:34.199+00:00",
"evidenceCheckedAt": "2026-04-25T00:11:32.447+00:00",
"generatedAt": "2026-05-21T21:51:38.374Z"
},
"limitations": [
"RegBase aggregates public Japanese government disclosures and does not provide a credit opinion.",
"English summaries are provided for reference. The original Japanese source is authoritative.",
"Possible or unresolved entity matches should be manually verified before use in a decision."
]
}The original Japanese disclosure is the authoritative record. Use possible or unresolved matches only as leads for manual review.
Language
日本語版を見る (Japanese)About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.